MA

Director Director DIN 08729017
DIN 08729017 First appointment Mar 2020 Primary industry BFSI
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Mar 2020
Shareholding value β€’β€’β€’β€’ Premium profile

About Mohd Asif

Data last updated:

Mohd Asif was a Director at Sammarsa Micro Finance Private Limited (2024–2025) and Director at Greenleafs Pharma (Opc) Private Limited (from 2020). The companies operate in BFSI.

DIN 08729017
Primary Designation Director
Industry BFSI
First Appointment 20 Mar 2020
Oldest Company Age 6 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director29 Oct 20242024Active
Director20 Mar 20202020Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Greenleafs Pharma (Opc) Private Limited
Sammarsa Micro Finance Private Limited
Premium access

Shareholding and investment profile for Mohd Asif

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Mohd Asif

Mohd Asif was first appointed on 20 Mar 2020 as Director at Greenleafs Pharma (Opc) Private Limited. The most recent appointment on record is 29 Oct 2024 at Sammarsa Micro Finance Private Limited.

Mohd Asif held 2 earlier board appointments: Sammarsa Micro Finance Private Limited (Director, 29 Oct 2024 to 05 Nov 2025); Greenleafs Pharma (Opc) Private Limited (Director, from 20 Mar 2020).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available